-

Guardian Pharmacy Services, Inc. to Participate in Upcoming J.P. Morgan Healthcare Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today confirmed the company will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The company’s leadership team will host investor meetings on Wednesday, January 14th, and present at 4:30 p.m. PT the same day.

A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be accessible shortly after the event and will remain available for 30 days.

About Guardian Pharmacy Services

Guardian Pharmacy Services is one of the nation’s leading long-term care pharmacy services companies. Through its locally‑based business model, Guardian partners with long-term care facilities (“LTCFs”) to deliver medications and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. With a growing network of more than 53 pharmacies nationwide, Guardian is dedicated to providing exceptional service to close to 204,000 residents (as of September 30, 2025).

Contacts

Investor Contact
Ashley Stockton
Senior Director, Investor Relations
IR@guardianpharmacy.net

Industry:

Guardian Pharmacy Services, Inc.

NYSE:GRDN
Release Versions
English

Contacts

Investor Contact
Ashley Stockton
Senior Director, Investor Relations
IR@guardianpharmacy.net

More News From Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the fourth quarter and full year ended December 31, 2025. The Company also raised its full-year 2026 Adjusted EBITDA guidance. Fourth Quarter Financial Results Revenue of $397.6 million, up 17% year-over-year with organic growth of 12%. Residents served ended the quarter at approximately 205,000, up 10%...

Guardian Pharmacy Services, Inc. to Participate in Upcoming Oppenheimer Healthcare MedTech & Services Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that the company will participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. Fred Burke, President and Chief Executive Officer, and David Morris, Chief Financial Officer, will participate in a fireside chat on Monday, March 16, 2026, at 10:40 a.m. Eastern Time. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be a...

Guardian Pharmacy Services, Inc. to Participate in Upcoming Raymond James Institutional Investor Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that the company will present at the Raymond James Institutional Investors Conference in Orlando, Florida on Monday, March 2 at 1:40 p.m. Eastern Time. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay of the webcast will be accessible shortly after the event and will remain available for 90 days. About Guardian Pharmacy Services Guardian Pharmacy Servi...
Back to Newsroom